Composite rating
—
Consensus
—
Target consensus
—
Recent activity
—
Last 30 days
No ratings snapshot in DB for this symbol yet.
No grades consensus available.
Peer comparables
Green = best, red = worst (per column)| Ticker | Mcap | P/E | P/S | EV/EBITDA | ROE | D/E | Div Yield |
|---|---|---|---|---|---|---|---|
VRDNViridian Therapeutics, Inc.Focus | — | — | — | — | — | — | — |
Analyst grade actions — 5 years
Stacked monthly countsNo analyst-grade actions in
analyst_grades for VRDN over the last 5 years.